Antiviral Treatment for Chickenpox
Oral acyclovir should be considered for persons at increased risk for moderate to severe varicella (those ≥12 years, chronic cutaneous/pulmonary disorders, long-term salicylate therapy, or intermittent corticosteroid use), but is NOT routinely recommended for otherwise healthy children due to insufficient clinical benefit to justify routine use. 1
Treatment Recommendations by Population
Healthy Children (<12 years)
- Routine acyclovir is NOT recommended for otherwise healthy children with chickenpox 1
- The clinical benefit (modest reduction in fever duration, new lesion formation, and symptom severity) does not justify routine administration
- When used, must be initiated within 24 hours of rash onset for any benefit 1, 2
- If treatment is pursued: Oral acyclovir 80 mg/kg/day (maximum 3,200 mg/day) in 4 divided doses for 5 days 2
- Note: 5 days of therapy is equivalent to 7 days 2
Adolescents and Adults (≥12 years)
- Oral acyclovir SHOULD be considered for this age group due to increased risk of moderate to severe disease 1
- Dosing: Acyclovir 800 mg orally 5 times daily, initiated within 24 hours of rash onset 3, 4
- Duration: 5-7 days (5 days is sufficient) 2
- Clinical trials demonstrate acyclovir is well-tolerated and effective in reducing duration and severity when started early 1
Immunocompromised Patients (All Ages)
- Intravenous acyclovir is the treatment of choice 1, 3, 4
- Dosing: 500 mg/m² or 10 mg/kg IV every 8 hours 4
- Duration: 7-10 days 5
- Must be initiated within 24 hours of rash onset for optimal efficacy 1
- Sequential therapy approach: After minimum 48 hours IV acyclovir, patients can transition to oral therapy if:
- Afebrile for 24 hours
- No new lesions for 24 hours
- No internal organ involvement
- Able to tolerate oral medications 5
- This approach reduces hospitalization duration while maintaining efficacy 5
Pregnant Women
- Intravenous acyclovir should be considered for serious complications (e.g., pneumonitis) 1
- For significant infection: Oral acyclovir 800 mg 5 times daily 6
- For varicella pneumonitis: IV acyclovir 10-15 mg/kg or 500 mg/m² every 8 hours for 5-10 days, started within 24-72 hours of rash onset 6
- Acyclovir is FDA Category B; registry data on 596 first-trimester exposures showed no increased birth defects 1
Critical Timing Considerations
The 24-hour window is crucial: Acyclovir efficacy is dramatically reduced when initiated >24 hours after rash onset 1, 2. However, some benefit may still occur when started on day 2 of rash (within 24-48 hours), particularly in adolescents and adults 2.
Important Caveats
- Acyclovir does NOT reduce transmission or duration of school absence 1
- Antibody response is preserved with acyclovir treatment 1
- Viral resistance has not been demonstrated with standard treatment courses 2
- Adequate hydration and renal function monitoring are essential, especially with IV dosing 4
- Acyclovir is NOT indicated for prophylaxis in healthy individuals after exposure—vaccination is preferred 1
Special Populations Requiring Consideration
Beyond age ≥12 years, consider acyclovir for:
- Chronic cutaneous disorders
- Chronic pulmonary disorders
- Long-term salicylate therapy
- Short, intermittent, or aerosolized corticosteroid courses
- Secondary household contacts (per some experts) 1